Related Experiment Video
Updated: Sep 30, 2025

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
Erucin inhibits osteoclast formation via suppressing cell-cell fusion molecule DC-STAMP without influencing
Tomohiro Takagi1,2, Hirofumi Inoue1, Shungo Fujii1,3
1Department of Nutritional Science and Food Safety, Faculty of Applied Bioscience, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo, 156-8502, Japan.
Objective:
Erucin (ERN), an isothiocyanate, is derived from the vegetable arugula. Although ERN has antitumor and antioxidant activity, the effect of ERN on osteoclast and osteoblast differentiation is not well documented. In this study, we evaluated the effects of ERN on osteoclast and osteoblast differentiation in vitro.
Results:
ERN significantly reduced the formation of 1α,25(OH)2D3-induced tartrate-resistant acid phosphatase (TRAP)-positive cells at non-cytotoxic concentrations. Furthermore, ERN downregulated the mRNA expression of osteoclast-associated genes, such as nuclear factor of activated T cells cytoplasmic-1, TRAP, and cathepsin K. In addition, ERN suppressed mRNA expression of dendritic cell specific transmembrane protein (DC-STAMP), which encodes cell-cell fusion. However, ERN did not affect mineralization by osteoblasts. Thus, our data suggest that ERN may attenuate osteoclastic bone resorption by inhibiting multinucleation of mononuclear pre-osteoclasts and by suppressing mRNA expression of DC-STAMP in bone marrow cells without influencing mineralization by osteoblasts.
Insights
Erucin (ERN), from arugula, inhibits osteoclast formation and bone resorption without affecting osteoblast function. This natural compound shows potential for managing bone-related conditions.
Area of Science:
- Biochemistry
- Cell Biology
- Bone Biology
Background:
- Erucin (ERN) is an isothiocyanate found in arugula.
- ERN exhibits known antitumor and antioxidant properties.
- The impact of ERN on osteoclast and osteoblast differentiation requires further investigation.
Purpose of the Study:
- To investigate the in vitro effects of ERN on osteoclast differentiation.
- To evaluate the influence of ERN on osteoblast differentiation and function.
Main Methods:
- Assessing the formation of tartrate-resistant acid phosphatase (TRAP)-positive cells induced by 1α,25(OH)₂D₃.
- Analyzing the mRNA expression of key osteoclast-associated genes (NFATc1, TRAP, cathepsin K, DC-STAMP).
- Evaluating the effect of ERN on osteoblast mineralization.
Main Results:
- ERN significantly reduced TRAP-positive cell formation at non-cytotoxic concentrations.
- ERN downregulated mRNA expression of osteoclastogenesis regulators (NFATc1, TRAP, cathepsin K) and DC-STAMP.
- ERN did not impede osteoblast mineralization.
Conclusions:
- ERN attenuates osteoclastic bone resorption.
- ERN inhibits osteoclast formation by suppressing mononuclear pre-osteoclast multinucleation and DC-STAMP expression.
- ERN's effects on bone resorption do not compromise osteoblast mineralization.
Related Concept Videos
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Bone Remodeling
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...

